Cas:2161-85-5 4,6-diacetylresorcinol manufacturer & supplier

Chemical Name:4,6-diacetylresorcinol

CAS.NO:2161-85-5

Synonyms:resodiacetophenone;1,1′-(4,6-Dihydroxy-1,3-phenylene)bisethanone;4,6-diacetoresorcinol;Ethanone,1,1′-(4,6-dihydroxy-1,3-phenylene)bis;MFCD00017655;1,1′-(4,6-Dihydroxy-1,3-phenylene)bisethanone;1,3-diacetyl-4,6-dihydroxybenzene;1-(5-acetyl-2,4-dihydroxyphenyl)ethan-1-one;1,1′-(4,6-dihydroxy-1,3-phenylene)diethanone;1,1′-(4,6-dimethyl-1,3-phenylene)-diethanone;4,6-Diacetylresorcinol;1,1‘-(4,6-Dihydroxy-1,3-phenylene)bisethanone;EINECS 218-482-8

Molecular Formula:C₁₀H₁₀O₄

Molecular Weight:194.18400

HS Code:2914400090

Physical and Chemical Properties:

Melting point:178-180 °C(lit.)

Boiling point:399.9ºC at 760mmHg

Density:1.3g/cm3

Index of Refraction:1.585

PSA:74.60000

Exact Mass:194.05800

LogP:1.50300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like resodiacetophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 218-482-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(5-acetyl-2,4-dihydroxyphenyl)ethan-1-one Use and application,1,3-diacetyl-4,6-dihydroxybenzene technical grade,usp/ep/jp grade.

Related News: The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 4,6-diacetylresorcinol manufacturer Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease. 4,6-diacetylresorcinol supplier Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms. 4,6-diacetylresorcinol vendor The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 4,6-diacetylresorcinol factory But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US.